Pages that link to "Q34540010"
Jump to navigation
Jump to search
The following pages link to A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group (Q34540010):
Displaying 50 items.
- Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association (Q22306331) (← links)
- Adenosine-diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus (Q24203035) (← links)
- Antiplatelet agents and anticoagulants for hypertension (Q24234617) (← links)
- Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients (Q24240326) (← links)
- Antiplatelet agents and anticoagulants for hypertension (Q24246637) (← links)
- Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke (Q24646522) (← links)
- Results of the Ticlid or Plavix Post-Stents (TOPPS) trial: do they justify the switch from ticlopidine to clopidogrel after coronary stent placement? (Q24792611) (← links)
- Is clopidogrel superior to aspirin in secondary prevention of vascular disease? (Q24792794) (← links)
- Long-Term Antiplatelet Mono- and Dual Therapies After Ischemic Stroke or Transient Ischemic Attack: Network Meta-Analysis (Q26797510) (← links)
- Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis (Q28076042) (← links)
- The role of warfarin and aspirin in secondary prevention of stroke (Q28167094) (← links)
- Anti-platelet agents in neurological practice (Q28167366) (← links)
- Secondary prevention of stroke: a practical guide to drug treatment (Q28167729) (← links)
- Clopidogrel's role in the management of atherosclerotic disease: a focus on acute coronary syndromes (Q28167896) (← links)
- Antiplatelet treatment for secondary prevention of acute ischemic stroke and transient ischemic attacks: mechanisms, choices and possible emerging patterns of use (Q28167899) (← links)
- Medical prevention of secondary stroke: a cardiologist's perspective (Q28168902) (← links)
- The results of MATCH: light or heat? (Q28171180) (← links)
- Leukocytoclastic vasculitis associated with ticlopidine (Q28174962) (← links)
- Protective effects of SM-20302, an orally active GPIIb/IIIa antagonist, in an ADP/epinephrine-induced guinea pig model of transient cerebral ischemia (Q28176497) (← links)
- Clinical use of new antithrombotic therapies for medical management of acute coronary syndromes (Q28177271) (← links)
- Antithrombotic and thrombolytic therapy for ischemic stroke (Q28180825) (← links)
- Antiaggregant and anticoagulant therapy in systemic lupus erythematosus and Hughes' syndrome (Q28182136) (← links)
- Antithrombotic effects of tetramethylpyrazine in in vivo experiments (Q28183304) (← links)
- Regular or "super-aspirins"? A review of thienopyridines or aspirin to prevent stroke (Q28183391) (← links)
- Indobufen: an updated review of its use in the management of atherothrombosis (Q28184824) (← links)
- Systematic review of antiplatelet therapy for the prevention of myocardial infarction, stroke or vascular death in patients with peripheral vascular disease (Q28185314) (← links)
- Study for determination of the optimal cessation period of therapy with anti-platelet agents prior to invasive endoscopic procedures (Q28186141) (← links)
- The role of adenosine 5'-diphosphate receptor blockade in patients with cardiovascular disease (Q28186354) (← links)
- The use of antiplatelet agents in acute cardiac care (Q28186375) (← links)
- Complications of oral antiplatelet medications (Q28187982) (← links)
- Antiplatelet agents for secondary prevention of ischemic stroke (Q28190669) (← links)
- Is acetylsalicylic acid plus dipyridamole superior to ASA alone for secondary prevention of stroke? (Q28191988) (← links)
- Prevention of ischemic stroke (Q28192311) (← links)
- Review of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agents (Q28192470) (← links)
- Choices in medical management for prevention of acute ischemic stroke (Q28192558) (← links)
- Economic evaluation of triflusal and aspirin in the treatment of acute myocardial infarction (Q28192692) (← links)
- Ischemic stroke prevention: an update on antiplatelet therapy (Q28193224) (← links)
- A benefit-risk assessment of agents used in the secondary prevention of stroke (Q28193940) (← links)
- Platelets: is aspirin sufficient or must we know how to pronounce abciximab? (Q28194426) (← links)
- Scientific and therapeutic advances in antiplatelet therapy (Q28194547) (← links)
- Antithrombotic drugs in the prevention of ischemic stroke (Q28194656) (← links)
- Utility of platelet adp receptor antagonism in the emergency department: a review (Q28194741) (← links)
- Antiplatelet prescribing patterns for TIA and ischemic stroke: the Indiana University experience (Q28195159) (← links)
- Antithrombotic effects of magnesium sulfate in in vivo experiments (Q28196324) (← links)
- Clinical pharmacokinetics of antiplatelet agents used in the secondary prevention of stroke (Q28196865) (← links)
- Current developments in anti-platelet therapy (Q28200685) (← links)
- The safety and efficacy of aspirin and clopidogrel as a combination treatment in patients with coronary heart disease (Q28200757) (← links)
- Antithrombotic therapy in hypertension: a Cochrane Systematic review (Q28213879) (← links)
- Adverse effects and drug interactions of antithrombotic agents used in prevention of ischaemic stroke (Q28218187) (← links)
- Recent advance in antiplatelet therapy: the mechanisms, evidence and approach to the problems (Q28218351) (← links)